Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Bladder cancer; Breast cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cancer; Sarcoma; Thyroid cancer
- Focus Adverse reactions
- Acronyms VOTRAGE
- 12 Feb 2018 Planned End Date changed from 1 Dec 2016 to 1 May 2019.
- 12 Feb 2018 Planned primary completion date changed from 1 Oct 2015 to 1 May 2019.
- 12 Feb 2018 Status changed from recruiting to active, no longer recruiting.